Ekram Gad

1.4k total citations
37 papers, 1.1k citations indexed

About

Ekram Gad is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ekram Gad has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 16 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Ekram Gad's work include Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (9 papers). Ekram Gad is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (9 papers). Ekram Gad collaborates with scholars based in United States, South Korea and Netherlands. Ekram Gad's co-authors include Mary L. Disis, Hailing Lu, Yushe Dang, Keith L. Knutson, Denise L. Cecil, Leanna J. Standish, Cynthia A. Wenner, Yi Yang, Jennifer S. Childs and Kyong Hwa Park and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Ekram Gad

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ekram Gad United States 20 663 513 369 91 89 37 1.1k
Wenqi Jiang China 13 426 0.6× 337 0.7× 268 0.7× 70 0.8× 199 2.2× 52 1.0k
Geetha Muthukumaran United States 14 400 0.6× 361 0.7× 220 0.6× 82 0.9× 107 1.2× 23 1.1k
Ganesan Ramamoorthi United States 18 364 0.5× 396 0.8× 431 1.2× 160 1.8× 45 0.5× 32 1.0k
Antonia Collado Spain 20 739 1.1× 430 0.8× 277 0.8× 70 0.8× 65 0.7× 30 1.2k
Marie P. Piechocki United States 20 444 0.7× 454 0.9× 524 1.4× 124 1.4× 34 0.4× 37 1.2k
Yuji Togashi Japan 20 575 0.9× 524 1.0× 328 0.9× 55 0.6× 24 0.3× 35 1.3k
Rajeev Shrimali United States 15 640 1.0× 865 1.7× 397 1.1× 114 1.3× 41 0.5× 24 1.5k
Bhawna Gupta India 19 391 0.6× 143 0.3× 435 1.2× 62 0.7× 40 0.4× 47 1.1k
Chen‐Hao Yeh United States 18 498 0.8× 142 0.3× 263 0.7× 37 0.4× 142 1.6× 20 1.1k
Anamika Bose India 26 1.0k 1.6× 619 1.2× 706 1.9× 176 1.9× 21 0.2× 87 1.9k

Countries citing papers authored by Ekram Gad

Since Specialization
Citations

This map shows the geographic impact of Ekram Gad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ekram Gad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ekram Gad more than expected).

Fields of papers citing papers by Ekram Gad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ekram Gad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ekram Gad. The network helps show where Ekram Gad may publish in the future.

Co-authorship network of co-authors of Ekram Gad

This figure shows the co-authorship network connecting the top 25 collaborators of Ekram Gad. A scholar is included among the top collaborators of Ekram Gad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ekram Gad. Ekram Gad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cecil, Denise L., Ekram Gad, Michael Gormley, et al.. (2022). Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer. Scientific Reports. 12(1). 13618–13618. 3 indexed citations
2.
Cecil, Denise L., Ekram Gad, Andrew L. Coveler, et al.. (2021). Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention. Frontiers in Immunology. 12. 729809–729809. 21 indexed citations
3.
Disis, Mary L., Ekram Gad, Denise L. Cecil, et al.. (2020). Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers. Molecular Cancer Therapeutics. 19(5). 1102–1109. 15 indexed citations
4.
Riolobos, Laura, Ekram Gad, Piper M. Treuting, et al.. (2019). The Effect of Mouse Strain, Sex, and Carcinogen Dose on Toxicity and the Development of Lung Dysplasia and Squamous Cell Carcinomas in Mice. Cancer Prevention Research. 12(8). 507–516. 9 indexed citations
5.
Stanton, Sasha E., et al.. (2019). Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets. Vaccine. 37(27). 3552–3561. 16 indexed citations
6.
Cecil, Denise L., Meredith Slota, Megan M. O’Meara, et al.. (2016). Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo. Clinical Cancer Research. 23(13). 3396–3404. 29 indexed citations
7.
Dang, Yushe, et al.. (2015). The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent. Clinical Cancer Research. 22(9). 2207–2216. 20 indexed citations
8.
Liao, John B., et al.. (2015). Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer. Journal for ImmunoTherapy of Cancer. 3(1). 16–16. 23 indexed citations
9.
Cecil, Denise L., Gregory E. Holt, Kyong Hwa Park, et al.. (2014). Elimination of IL-10–Inducing T-Helper Epitopes from an IGFBP-2 Vaccine Ensures Potent Antitumor Activity. Cancer Research. 74(10). 2710–2718. 38 indexed citations
10.
Gad, Ekram, Meredith Slota, Piper M. Treuting, et al.. (2014). Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models. Breast Cancer Research and Treatment. 148(3). 501–510. 7 indexed citations
11.
Mao, Jianning, Jon J. Ladd, Ekram Gad, et al.. (2014). Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer. Journal of Translational Medicine. 12(1). 121–121. 20 indexed citations
12.
Disis, Mary L., Ekram Gad, Daniel R. Herendeen, et al.. (2013). A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease. Cancer Prevention Research. 6(12). 1273–1282. 59 indexed citations
13.
Engel, Abbi L., Ekram Gad, Yi Yang, et al.. (2013). Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant. Immunobiology. 218(12). 1468–1476. 28 indexed citations
14.
15.
Lu, Hailing, Yi Yang, Ekram Gad, et al.. (2011). TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy. Clinical Cancer Research. 17(21). 6742–6753. 71 indexed citations
16.
Lu, Hailing, Yi Yang, Ekram Gad, et al.. (2010). Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells. Clinical Cancer Research. 17(1). 67–76. 125 indexed citations
17.
Lu, Hailing, Wolfgang Wagner, Ekram Gad, et al.. (2010). Treatment Failure of a TLR-7 Agonist Occurs Due to Self-Regulation of Acute Inflammation and Can Be Overcome by IL-10 Blockade. The Journal of Immunology. 184(9). 5360–5367. 64 indexed citations
18.
Yang, Yi, et al.. (2009). The role of TLR2 in the immunostimulatory effect of Polysaccharide krestin (PSK) (41.13). The Journal of Immunology. 182(Supplement_1). 41.13–41.13. 1 indexed citations
19.
Lu, Hailing, Keith L. Knutson, Ekram Gad, & Mary L. Disis. (2006). The Tumor Antigen Repertoire Identified in Tumor-Bearing Neu Transgenic Mice Predicts Human Tumor Antigens. Cancer Research. 66(19). 9754–9761. 49 indexed citations
20.
Knutson, Keith L., Yushe Dang, Hailing Lu, et al.. (2006). IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu -Transgenic Mice. The Journal of Immunology. 177(1). 84–91. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenqi Jiang Breakdown of academic impact, for papers by Geetha Muthukumaran Breakdown of academic impact, for papers by Ganesan Ramamoorthi Breakdown of academic impact, for papers by Antonia Collado Breakdown of academic impact, for papers by Marie P. Piechocki Breakdown of academic impact, for papers by Yuji Togashi Breakdown of academic impact, for papers by Rajeev Shrimali Breakdown of academic impact, for papers by Bhawna Gupta Breakdown of academic impact, for papers by Chen‐Hao Yeh Breakdown of academic impact, for papers by Anamika Bose
Rankless by CCL
2026